Skip to main content
Market intelligence
FDMTHealthcare

4D Molecular Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 23, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 23, 2026Scott BizilyChief Legal OfficerSale9,810$12.00$117,720
Jun 22, 2026David KirnSee RemarksSale114,746$10.47$1,200,851
Jun 1, 2026David KirnSee RemarksSale1,922$10.02$19,258